Your search returned 9 results.

Sort
Results
1.
PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31186300
Year: 2019
Citation:
  • Diabetes Care. 42(9):1724-1732, 2019 09.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Altuntas Y, Aroda VR, Christiansen E, Haluzik M, Hertz CL, Jeppesen OK, Lalic NM, Morales Villegas EC, PIONEER 1 Investigators, Rosenstock J, Terauchi Y
2.
Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials. MedStar authors:
  • Weissman, Neil J
PMID:
  • 27888609
Year: 2017
Citation:
  • Obesity. 25(1):39-44, 2017 Jan
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Fain R, Hall N, Shanahan WR, Smith SR, Weissman NJ
3.
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31530667
Year: 2019
Citation:
  • Diabetes Care. 42(12):2262-2271, 2019 12.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Araki E, Aroda VR, Buse JB, Cariou B, Harris SB, Hoff ST, Pedersen KB, PIONEER 8 investigators, Tarp-Johansen MJ, Zinman B
4.
A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials. [Review] MedStar authors:
  • Aroda, Vanita R
PMID:
  • 29364586
Year: 2018
Citation:
  • Diabetes, Obesity & Metabolism. 20 Suppl 1:22-33, 2018 02.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Aroda VR
5.
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients. MedStar authors:
  • Weissman, Neil J
PMID:
  • 30145941
Year: 2018
Citation:
  • New England Journal of Medicine. 379(12):1107-1117, 2018 09 20.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bohula EA, Bonaca MP, Brown C, Budaj A, CAMELLIA-TIMI 61 Steering Committee and Investigators, Dhadda S, Fanola CL, Francis B, Garcia-Castillo A, Gupta M, Im K, Inzucchi SE, Keech AC, Kuder J, Leiter LA, McGuire DK, Miao W, Patel T, Perdomo C, Qamar A, Ruff CT, Sabatine MS, Scirica BM, Smith SR, Weissman NJ, White HD, Wiviott SD
6.
Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. MedStar authors:
  • Weissman, Neil J
PMID:
  • 22421927
Year: 2012
Citation:
  • Obesity. 20(7):1426-36, 2012 Jul.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Anderson CM, Fidler MC, O'Neil PM, Raether B, Sanchez M, Shanahan WR, Smith SR, Weissman NJ, Zhang J
7.
Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 32139384
Year: 2020
Citation:
  • Diabetes Care. 43(5):940-947, 2020 05.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Butera NM, Camp AW, Cherrington A, Craig J, Fortmann SP, GRADE Research Group, Hollander PA, Krakoff J, Perez M, Phillips LS, Rasouli N, Sivitz WI, Tan MH, Tiktin M, Wexler DJ, Younes N
8.
Echocardiographic assessment of cardiac valvular regurgitation with lorcaserin from analysis of 3 phase 3 clinical trials. MedStar authors:
  • Weissman, Neil J
PMID:
  • 23661689
Year: 2013
Citation:
  • Circulation. Cardiovascular imaging. 6(4):560-7, 2013 Jul.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Clinical Trial, Phase III
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Anderson CM, Koch GG, Sanchez M, Shanahan WR, Smith SR, Weissman NJ
9.
Neuropsychiatric safety with liraglutide 3.0mg for weight management: results from randomized controlled phase 2 and 3a trials. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 28386912
Year: 2017
Citation:
  • Diabetes, Obesity & Metabolism. 19(11):1529-1536, 2017 Nov.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Astrup A, Brett J, Cancino A, Kushner R, Lau DC, O'Neil PM, Satiety and Clinical Adiposity - Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups, Wadden TA, Wilding JP
Pages

Powered by Koha